Physicians serving as clinical investigators in Knoxville, Tennessee, working for Alliance for Multispecialty Research (AMR) and the University of Tennessee Medical Center, initiated a clinical…
AzurRx BioPharma announced results from its phase 2 trial evaluating MS1819 in combination with the current standard of care, porcine-derived pancreatic enzyme replacement therapy (PERT), for…
Coherus Biosciences and Junshi Biosciences announced positive interim from the phase 3 CHOICE-01 trial evaluating toripalimab plus chemotherapy as first-line treatment of advanced squamous or…
Vertex Pharmaceuticals reported results from a phase 2 study evaluating the efficacy and safety of VX-864 in patients with alpha-1 antitrypsin deficiency (AATD) with the…
AstraZeneca presented data from two phase 3 trials at the annual American Society for Clinical Oncology (ASCO) meeting. The first data presentation was for the…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
